IMTX stock stays in focus as price and targets align
Published on 09/20/2026 at 19:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
IMTX stock (ISIN NL0015255052) traded at USD 7.70 on September 19, 2026, after a recent session move of 0.0 percent, while the same market snapshot put market capitalization at USD 848.0 million and 52-week trading at USD 3.60 to USD 8.95.
Consensus points higher
According to MarketBeat, the analyst consensus for IMTX stock stands at USD 15.50, with 4 Buy ratings and 12 analysts in the current overview. That compares with the USD 7.70 close and implies a gap of about 101.3 percent.
The company reported second-quarter 2026 revenue of USD 7.3 million and a net loss of USD 47.2 million, while cash and cash equivalents were USD 772.4 million at June 30, 2026. Those figures frame the operating story behind the share price more clearly than a single day move.
Cash still matters
For investors, the cash balance is the clearest buffer in the current setup. A reported USD 772.4 million at June 30, 2026 gives IMTX room to fund development while revenue remained at USD 7.3 million in Q2 2026.
Stock near the high
At USD 7.70 on September 19, 2026, the stock sat 14.0 percent below the 52-week high of USD 8.95 and 113.9 percent above the 52-week low of USD 3.60.
IMTX stock snapshot
- Company: Immatics N.V.
- ISIN: NL0015255052
- Ticker: IMTX
- Trading venue: Nasdaq
- Price (as of September 19, 2026): USD 7.70
- Market capitalization: USD 848.0 million (as of September 19, 2026)
- Sector / Industry: Health Care / Biotechnology
- Index membership: Not in a major U.S. benchmark index
